Stroke is one of the leading causes of death in the western world. During a stroke, blood flow to parts of the brain is obstructed, followed by a rapid decrease of oxygen and energy supply to the brain tissue. 

During the last days, NNN has been profiling Norwegian neuroscience at the NLSDays in Stockholm. We chaired the neuroscience session, were interviewed by PharmaTelevision, met a range of interesting partners, and had the most visited stand at the conference together with Oslo Cancer Cluster.

We are happy to announce that Innovation Norway have decided to continue supporting the development of NNN. Through an agreement signed in July, Innovation Norway has committed to maintaining NNN’s status as National Innovation Network throughout 2015.

NNN-member Pre Diagnostics was established in 2013 by Erik Christensen and Håkon Sæterøy. The company seeks to develop and commercialize an innovative and very effective diagnostic test for Alzheimer’s disease.

NNN will host an exciting neuroscience session at the Nordic Life Science Days in Stockholm 7.-9. September. 

On August 18th, NNN published a newspaper supplement in Dagens Næringsliv. This is the first time NNN makes use of this channel to reach a broader audience. 

Sarsia Seed partner Sveinung Hole joins the NNN board. Erik Christensen reelected as chairman.The annual NNN General Assembly was held in Oslo Science Park on June 10th, in connection with the NNN member meeting and summer party. 

​The HelseOmsorg21 strategy was presented to Prime Minister Erna Solberg and Health Minister Bent Høie Wednesday this week. Read the main priorities here. 

Pages